Tag: tumor treating fields

Complement mutation linked to poor response to eculizumab

Tumor Treating Fields vs Standard Therapy in Treatment-Resistant Metastatic NSCLC

byDaniel Goldshteinand1 others

September 25, 2023

1. The median OS was 13.2 months with TTFields arm vs 9.9 months with standard arm, with an HR of ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Preweekend surgeries may have higher risks of complications and mortality
Short sleep duration associated with increased risk of diabetes
AAV9.LAMP2B gene therapy shows clinical benefit in Danon disease

No Result

View All Result